“…In addition, a significant decrease in the turnover rate in jawbones was observed in both humans and animals after bisphosphonate administration (Allen, Iwata, Phipps, & Burr, 2006;Recker et al, 2006). Furthermore, due to T A B L E 1 Embryological, anatomical, and biochemical differences between the craniofacial region and the appendicular skeleton the higher calcium content in the mandible than in the femur and tibia, bisphosphonates might be absorbed in greater quantity in the mandible (Sasaki, Matsuura, Katafuchi, Tokutomi, & Sato, 2010). Indeed, higher bone density in mandibular bone has been observed in BRONJ patients (Heim, Götz, Kramer, & Faron, 2019).…”